The high cost of pharmaceuticals: Canada’s drug problem

CBC’s Fifth Estate featured an interview with Steve Morgan, a professor in UBC’s school of population and public health, about the Canadian pharmaceutical industry.

He said “we really need to think carefully about making sure that a drug benefits system in this country, a pharmaceutical strategy in Canada, is grounded entirely on good quality clinical evidence.”